Amgen Inc. beat EPS estimates 94% of the time across 18 reported quarters (17 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $5.55 | — | — | Miss |
| Q1 FY2026 | $4.77 | — | — | Miss |
| Q1 FY2026 | $4.77 | $5.15 | +8.0% | Beat |
| 2026-02-03 | $4.73 | $5.29 | +11.8% | Beat |
| Q3 FY2025 | $5.02 | $5.64 | +12.3% | Beat |
| Q2 FY2025 | $5.28 | $6.02 | +14.0% | Beat |
| Q1 FY2025 | $4.27 | $4.90 | +14.8% | Beat |
| 2025-02-04 | $5.04 | $5.31 | +5.4% | Beat |
| Q3 FY2024 | $5.11 | $5.58 | +9.2% | Beat |
| Q3 FY2024 | $4.98 | $4.97 | -0.2% | Miss |
| Q3 FY2024 | $3.88 | $3.96 | +2.1% | Beat |
| 2024-02-06 | $4.59 | $4.71 | +2.6% | Beat |
Back to AMGN overview · AMGN holders · AMGN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.